A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Royal Marsden NHS Foundation Trust
VLP Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
University of Chicago
Sanford Health
Bicara Therapeutics
Leap Therapeutics, Inc.
Carisma Therapeutics Inc
Seagen Inc.
Fate Therapeutics